Enalapril in low-renin essential hypertension

Clinical Pharmacology and Therapeutics

Volumn 34, Issue 3, 1983, Pages 297-302

  Wilkins, Linda H ^a,b   Dustan, Harriet P ^a,b   Findlay Walker, J ^a,b   Oparil, Suzanne ^a,b  

^a Division of Cardiology   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRIL; PLACEBO;

ADVERSE DRUG REACTION; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG THERAPY; ESSENTIAL HYPERTENSION; HUMAN; HYPERTENSION; ORAL DRUG ADMINISTRATION; THERAPY;

ADULT; AGED; BLOOD PRESSURE; DIPEPTIDES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION; ENALAPRIL; FEMALE; HUMAN; HYPERTENSION; MALE; MIDDLE AGE; PEPTIDYL-DIPEPTIDASE A; RANDOM ALLOCATION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0020571392     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.1983.171     Document Type: Article

References (20)